Gardam S[Author] - Search Results

Year	Number of Results
2003	1
2004	3
2005	2
2006	1
2008	1
2009	1
2010	2
2011	3
2014	1
2015	3
2023	0

1

The kinase NIK as a therapeutic target in multiple myeloma.

Gardam S, Beyaert R. Gardam S, et al. Expert Opin Ther Targets. 2011 Feb;15(2):207-18. doi: 10.1517/14728222.2011.548861. Epub 2011 Jan 5. Expert Opin Ther Targets. 2011. PMID: 21204728 Review.

2

In vivo control of B-cell survival and antigen-specific B-cell responses.

Chan TD, Gardam S, Gatto D, Turner VM, Silke J, Brink R. Chan TD, et al. Among authors: gardam s. Immunol Rev. 2010 Sep;237(1):90-103. doi: 10.1111/j.1600-065X.2010.00942.x. Immunol Rev. 2010. PMID: 20727031 Review.

3

Non-Canonical NF-κB Signaling Initiated by BAFF Influences B Cell Biology at Multiple Junctures.

Gardam S, Brink R. Gardam S, et al. Front Immunol. 2014 Jan 6;4:509. doi: 10.3389/fimmu.2013.00509. eCollection 2014 Jan 6. Front Immunol. 2014. PMID: 24432023 Free PMC article. Review.

4

XEDAR activates the non-canonical NF-κB pathway.

Verhelst K, Gardam S, Borghi A, Kreike M, Carpentier I, Beyaert R. Verhelst K, et al. Among authors: gardam s. Biochem Biophys Res Commun. 2015 Sep 18;465(2):275-80. doi: 10.1016/j.bbrc.2015.08.019. Epub 2015 Aug 8. Biochem Biophys Res Commun. 2015. PMID: 26260321

5

Lineage-specific transgene expression in hematopoietic cells using a Cre-regulated retroviral vector.

Turner VM, Gardam S, Brink R. Turner VM, et al. Among authors: gardam s. J Immunol Methods. 2010 Aug 31;360(1-2):162-6. doi: 10.1016/j.jim.2010.06.007. Epub 2010 Jun 17. J Immunol Methods. 2010. PMID: 20600080

6

TRAF2 regulates peripheral CD8(+) T-cell and NKT-cell homeostasis by modulating sensitivity to IL-15.

Villanueva JE, Malle EK, Gardam S, Silveira PA, Zammit NW, Walters SN, Brink R, Grey ST. Villanueva JE, et al. Among authors: gardam s. Eur J Immunol. 2015 Jun;45(6):1820-31. doi: 10.1002/eji.201445416. Epub 2015 May 26. Eur J Immunol. 2015. PMID: 25931426 Free article.

7

The SW(HEL) system for high-resolution analysis of in vivo antigen-specific T-dependent B cell responses.

Brink R, Paus D, Bourne K, Hermes JR, Gardam S, Phan TG, Chan TD. Brink R, et al. Among authors: gardam s. Methods Mol Biol. 2015;1291:103-23. doi: 10.1007/978-1-4939-2498-1_9. Methods Mol Biol. 2015. PMID: 25836305

8

Increased CD4+Foxp3+ T cells in BAFF-transgenic mice suppress T cell effector responses.

Walters S, Webster KE, Sutherland A, Gardam S, Groom J, Liuwantara D, Mariño E, Thaxton J, Weinberg A, Mackay F, Brink R, Sprent J, Grey ST. Walters S, et al. Among authors: gardam s. J Immunol. 2009 Jan 15;182(2):793-801. doi: 10.4049/jimmunol.182.2.793. J Immunol. 2009. PMID: 19124722

9

TRAF2 and TRAF3 signal adapters act cooperatively to control the maturation and survival signals delivered to B cells by the BAFF receptor.

Gardam S, Sierro F, Basten A, Mackay F, Brink R. Gardam S, et al. Immunity. 2008 Mar;28(3):391-401. doi: 10.1016/j.immuni.2008.01.009. Epub 2008 Feb 28. Immunity. 2008. PMID: 18313334 Free article.

10

TRAF2 differentially regulates the canonical and noncanonical pathways of NF-kappaB activation in mature B cells.

Grech AP, Amesbury M, Chan T, Gardam S, Basten A, Brink R. Grech AP, et al. Among authors: gardam s. Immunity. 2004 Nov;21(5):629-42. doi: 10.1016/j.immuni.2004.09.011. Immunity. 2004. PMID: 15539150 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results